SrasV1, PubMed, Curation, bibRecord, 001963

Rapid and real-time detection technologies for emerging viruses of biomedical importance.

Identifieur interne : 001963 ( PubMed/Curation ); précédent : 001962; suivant : 001964

Rapid and real-time detection technologies for emerging viruses of biomedical importance.

Auteurs : M M Parida [Inde]

Source :

Journal of biosciences [ 0250-5991 ] ; 2008.

RBID : pubmed:19208986

Descripteurs français

KwdFr :
- ADN viral (), ARN viral (), Amorces ADN, Humains, Maladies transmissibles émergentes (diagnostic), Maladies transmissibles émergentes (virologie), Maladies virales (diagnostic), RT-PCR, Sensibilité et spécificité, Sérotypage (), Techniques d'amplification d'acides nucléiques, Techniques et procédures diagnostiques, Virus (génétique), Virus (isolement et purification).
MESH :
- diagnostic : Maladies transmissibles émergentes, Maladies virales.
- génétique : Virus.
- isolement et purification : Virus.
- virologie : Maladies transmissibles émergentes.
- ADN viral, ARN viral, Amorces ADN, Humains, RT-PCR, Sensibilité et spécificité, Sérotypage, Techniques d'amplification d'acides nucléiques, Techniques et procédures diagnostiques.

English descriptors

KwdEn :
- Communicable Diseases, Emerging (diagnosis), Communicable Diseases, Emerging (virology), DNA Primers, DNA, Viral (chemistry), Diagnostic Techniques and Procedures, Humans, Nucleic Acid Amplification Techniques, RNA, Viral (chemistry), Reverse Transcriptase Polymerase Chain Reaction, Sensitivity and Specificity, Serotyping (methods), Virus Diseases (diagnosis), Viruses (genetics), Viruses (isolation & purification).
MESH :
- chemical , chemistry : DNA, Viral, RNA, Viral.
- chemical : DNA Primers.
- diagnosis : Communicable Diseases, Emerging, Virus Diseases.
- genetics : Viruses.
- isolation & purification : Viruses.
- methods : Serotyping.
- virology : Communicable Diseases, Emerging.
- Diagnostic Techniques and Procedures, Humans, Nucleic Acid Amplification Techniques, Reverse Transcriptase Polymerase Chain Reaction, Sensitivity and Specificity.

Abstract

The development of technologies with rapid and sensitive detection capabilities and increased throughput have become crucial for responding to greater number threats posed by emerging and re-emerging viruses in the recent past. The conventional identification methods require time-consuming culturing, and/or detection of antibodies,which are not very sensitive and specific. The recent advances in molecular biology techniques in the field of genomics and proteomics greatly facilitate the rapid identification with more accuracy. We have developed two real-time assays ie., SYBR green I based real time reverse transcription polymerase chain reaction (RT-PCR) and RT-loop-mediated isothermal amplification (LAMP) assay for rapid detection as well as typing of some of the emerging viruses of biomedical importance viz. dengue, Japanese encephalitis, chikungunya, west Nile, severe acute respiratory syndrome virus (SARS) etc. Both these techniques are capable of detection and differentiation as well as quantifying viral load with higher sensitivity, rapidity, specificity. One of the most important advantages of LAMP is its field applicability, without requirement of any sophisticated equipments. Both these assays have been extensively evaluated and validated with clinical samples of recent epidemics from different parts of India. The establishment of these real time molecular assays will certainly facilitate the rapid detection of viruses with high degree of precision and accuracy in future.

DOI: 10.1007/s12038-008-0079-7
PubMed: 19208986

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001963

Links to Exploration step

pubmed:19208986

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Rapid and real-time detection technologies for emerging viruses of biomedical importance.</title>
<author><name sortKey="Parida, M M" sort="Parida, M M" uniqKey="Parida M" first="M M" last="Parida">M M Parida</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Virology, Defence R and D Establishment, Gwalior 474 002, India. paridamm@rediffmail.com</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Department of Virology, Defence R and D Establishment, Gwalior 474 002</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2008">2008</date>
<idno type="RBID">pubmed:19208986</idno>
<idno type="pmid">19208986</idno>
<idno type="doi">10.1007/s12038-008-0079-7</idno>
<idno type="wicri:Area/PubMed/Corpus">001963</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001963</idno>
<idno type="wicri:Area/PubMed/Curation">001963</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001963</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Rapid and real-time detection technologies for emerging viruses of biomedical importance.</title>
<author><name sortKey="Parida, M M" sort="Parida, M M" uniqKey="Parida M" first="M M" last="Parida">M M Parida</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Virology, Defence R and D Establishment, Gwalior 474 002, India. paridamm@rediffmail.com</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Department of Virology, Defence R and D Establishment, Gwalior 474 002</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series><title level="j">Journal of biosciences</title>
<idno type="ISSN">0250-5991</idno>
<imprint><date when="2008" type="published">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Communicable Diseases, Emerging (diagnosis)</term>
<term>Communicable Diseases, Emerging (virology)</term>
<term>DNA Primers</term>
<term>DNA, Viral (chemistry)</term>
<term>Diagnostic Techniques and Procedures</term>
<term>Humans</term>
<term>Nucleic Acid Amplification Techniques</term>
<term>RNA, Viral (chemistry)</term>
<term>Reverse Transcriptase Polymerase Chain Reaction</term>
<term>Sensitivity and Specificity</term>
<term>Serotyping (methods)</term>
<term>Virus Diseases (diagnosis)</term>
<term>Viruses (genetics)</term>
<term>Viruses (isolation & purification)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>ADN viral ()</term>
<term>ARN viral ()</term>
<term>Amorces ADN</term>
<term>Humains</term>
<term>Maladies transmissibles émergentes (diagnostic)</term>
<term>Maladies transmissibles émergentes (virologie)</term>
<term>Maladies virales (diagnostic)</term>
<term>RT-PCR</term>
<term>Sensibilité et spécificité</term>
<term>Sérotypage ()</term>
<term>Techniques d'amplification d'acides nucléiques</term>
<term>Techniques et procédures diagnostiques</term>
<term>Virus (génétique)</term>
<term>Virus (isolement et purification)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>DNA, Viral</term>
<term>RNA, Viral</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>DNA Primers</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Communicable Diseases, Emerging</term>
<term>Virus Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Maladies transmissibles émergentes</term>
<term>Maladies virales</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Viruses</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Viruses</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Serotyping</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Maladies transmissibles émergentes</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Communicable Diseases, Emerging</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Diagnostic Techniques and Procedures</term>
<term>Humans</term>
<term>Nucleic Acid Amplification Techniques</term>
<term>Reverse Transcriptase Polymerase Chain Reaction</term>
<term>Sensitivity and Specificity</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>ADN viral</term>
<term>ARN viral</term>
<term>Amorces ADN</term>
<term>Humains</term>
<term>RT-PCR</term>
<term>Sensibilité et spécificité</term>
<term>Sérotypage</term>
<term>Techniques d'amplification d'acides nucléiques</term>
<term>Techniques et procédures diagnostiques</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The development of technologies with rapid and sensitive detection capabilities and increased throughput have become crucial for responding to greater number threats posed by emerging and re-emerging viruses in the recent past. The conventional identification methods require time-consuming culturing, and/or detection of antibodies,which are not very sensitive and specific. The recent advances in molecular biology techniques in the field of genomics and proteomics greatly facilitate the rapid identification with more accuracy. We have developed two real-time assays ie., SYBR green I based real time reverse transcription polymerase chain reaction (RT-PCR) and RT-loop-mediated isothermal amplification (LAMP) assay for rapid detection as well as typing of some of the emerging viruses of biomedical importance viz. dengue, Japanese encephalitis, chikungunya, west Nile, severe acute respiratory syndrome virus (SARS) etc. Both these techniques are capable of detection and differentiation as well as quantifying viral load with higher sensitivity, rapidity, specificity. One of the most important advantages of LAMP is its field applicability, without requirement of any sophisticated equipments. Both these assays have been extensively evaluated and validated with clinical samples of recent epidemics from different parts of India. The establishment of these real time molecular assays will certainly facilitate the rapid detection of viruses with high degree of precision and accuracy in future.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19208986</PMID>
<DateCompleted><Year>2009</Year>
<Month>04</Month>
<Day>09</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>03</Month>
<Day>25</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0250-5991</ISSN>
<JournalIssue CitedMedium="Print"><Volume>33</Volume>
<Issue>4</Issue>
<PubDate><Year>2008</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Journal of biosciences</Title>
<ISOAbbreviation>J. Biosci.</ISOAbbreviation>
</Journal>
<ArticleTitle>Rapid and real-time detection technologies for emerging viruses of biomedical importance.</ArticleTitle>
<Pagination><MedlinePgn>617-28</MedlinePgn>
</Pagination>
<Abstract><AbstractText>The development of technologies with rapid and sensitive detection capabilities and increased throughput have become crucial for responding to greater number threats posed by emerging and re-emerging viruses in the recent past. The conventional identification methods require time-consuming culturing, and/or detection of antibodies,which are not very sensitive and specific. The recent advances in molecular biology techniques in the field of genomics and proteomics greatly facilitate the rapid identification with more accuracy. We have developed two real-time assays ie., SYBR green I based real time reverse transcription polymerase chain reaction (RT-PCR) and RT-loop-mediated isothermal amplification (LAMP) assay for rapid detection as well as typing of some of the emerging viruses of biomedical importance viz. dengue, Japanese encephalitis, chikungunya, west Nile, severe acute respiratory syndrome virus (SARS) etc. Both these techniques are capable of detection and differentiation as well as quantifying viral load with higher sensitivity, rapidity, specificity. One of the most important advantages of LAMP is its field applicability, without requirement of any sophisticated equipments. Both these assays have been extensively evaluated and validated with clinical samples of recent epidemics from different parts of India. The establishment of these real time molecular assays will certainly facilitate the rapid detection of viruses with high degree of precision and accuracy in future.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Parida</LastName>
<ForeName>M M</ForeName>
<Initials>MM</Initials>
<AffiliationInfo><Affiliation>Department of Virology, Defence R and D Establishment, Gwalior 474 002, India. paridamm@rediffmail.com</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D023361">Validation Study</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>India</Country>
<MedlineTA>J Biosci</MedlineTA>
<NlmUniqueID>8100809</NlmUniqueID>
<ISSNLinking>0250-5991</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D017931">DNA Primers</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004279">DNA, Viral</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D021821" MajorTopicYN="N">Communicable Diseases, Emerging</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017931" MajorTopicYN="N">DNA Primers</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004279" MajorTopicYN="N">DNA, Viral</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019937" MajorTopicYN="N">Diagnostic Techniques and Procedures</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D021141" MajorTopicYN="N">Nucleic Acid Amplification Techniques</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D020133" MajorTopicYN="N">Reverse Transcriptase Polymerase Chain Reaction</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012703" MajorTopicYN="N">Serotyping</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014777" MajorTopicYN="N">Virus Diseases</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014780" MajorTopicYN="N">Viruses</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year>
<Month>2</Month>
<Day>12</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2009</Year>
<Month>2</Month>
<Day>12</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2009</Year>
<Month>4</Month>
<Day>10</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">19208986</ArticleId>
<ArticleId IdType="doi">10.1007/s12038-008-0079-7</ArticleId>
<ArticleId IdType="pmc">PMC7090734</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>J Med Virol. 2005 Apr;75(4):583-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15714482</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nucleic Acids Res. 2000 Jun 15;28(12):E63</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10871386</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Issues Mol Biol. 2007 Jul;9(2):87-102</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17489437</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol Methods. 2004 Jan;115(1):1-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14656455</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Virol. 2006 Apr;35(4):355-67</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16460999</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Microbiol Rev. 2006 Jan;19(1):165-256</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16418529</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 2006 Apr;44(4):1295-304</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16597854</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 2004 Jan;42(1):257-63</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14715762</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 2003 Jun;41(6):2408-16</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12791857</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Cell Probes. 2002 Jun;16(3):223-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12144774</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 2007 Feb;45(2):351-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17135444</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 2005 Feb;43(2):951-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15695716</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 2004 May;42(5):1956-61</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15131154</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2004 Jan 15;38(2):293-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14699465</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biochem Biophys Methods. 2004 May 31;59(2):145-57</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15163526</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol Methods. 2007 Jul;143(1):73-80</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17403544</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Virol. 2002 Dec;25 Suppl 3:S3-12</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12467772</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Biophys Res Commun. 2001 Nov 23;289(1):150-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11708792</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Microbiol Immunol. 2006;50(5):379-87</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16714845</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 2001 Nov;39(11):4093-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11682535</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol Methods. 2002 Sep;105(2):277-85</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12270660</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Med Virol. 2005 Mar;75(3):470-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15648065</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Aspects Med. 2006 Apr-Jun;27(2-3):254-98</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16481036</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nucleic Acids Res. 2002 Mar 15;30(6):1292-305</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11884626</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Med Virol. 2007 May;79(5):605-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17385684</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol Methods. 2004 Apr;117(1):67-74</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15019261</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 2006 Apr;44(4):1376-81</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16597865</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Virol. 2007 Jul;39(3):188-93</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17553740</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMC Biotechnol. 2006 Jan 10;6:3</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16401354</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Vet Sci. 2004 Dec;5(4):345-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15613819</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 2005 Jul;43(7):3290-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16000450</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Virol. 2003 Dec;28(3):233-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14522060</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Uirusu. 2004 Jun;54(1):107-12</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15449911</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2006 Nov 10;24(44-46):6679-82</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16797110</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 2006 Nov;44(11):4172-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17005741</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Med Virol. 2004 Dec;74(4):677-82</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15484264</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2005 Aug;11(8):1303-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16102326</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 2004 Apr;42(4):1564-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15071005</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 2005 Jun;43(6):2895-903</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15956414</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMC Infect Dis. 2004 Jun 09;4:15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15186502</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol Methods. 2006 Mar;132(1-2):216-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16289345</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001963 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 001963 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:19208986
   |texte=   Rapid and real-time detection technologies for emerging viruses of biomedical importance.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:19208986" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021

	Serveur d'exploration SRAS
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration SRAS

Rapid and real-time detection technologies for emerging viruses of biomedical importance.

Rapid and real-time detection technologies for emerging viruses of biomedical importance.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki